{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T06:53:39Z","timestamp":1756191219612},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Diaverum AB"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Experiences from the first wave of the 2019 coronavirus disease (COVID-19) pandemic can aid in the development of future preventive strategies. To date, risk prediction models for COVID-19-related incidence and outcomes in hemodialysis (HD) patients are missing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We developed risk prediction models for COVID-19 incidence and mortality among HD patients. We studied 38\u2009256 HD patients from a multi-national dialysis cohort between 3 March and 3 July 2020. Risk prediction models were developed and validated, based on predictors readily available in outpatient HD units. We compared mortality among patients with and without COVID-19, matched for age, sex and diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>During the observational period, 1259 patients (3.3%) acquired COVID-19. Of these, 62% were hospitalized or died. Mortality was 22% among COVID-19 patients with odds ratios 219.8 [95% confidence interval (CI) 80.6\u2013359] to 342.7 (95% CI 60.6\u201313\u2009595.1), compared to matched patients without COVID-19. Since the first wave of the pandemic affected most European countries during the study, the risk prediction model for incidence of COVID-19 was developed and validated in European patients only [N\u2009=\u200922\u2009826 area under the ROC curve(AUC)Dev 0.64, AUCVal 0.69]. The model for prediction of mortality was developed in all COVID-19 patients (AUCDev 0.71, AUCVal 0.78). Angiotensin receptor blockers were independently associated with a lower incidence of COVID-19 in European patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We identified modifiable risk factors for COVID-19 incidence and outcome in HD patients. Our risk prediction tools can be readily applied in clinical practice. This can aid in the development of preventive strategies for future waves of COVID-19.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfab037","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:03:48Z","timestamp":1612397028000},"page":"805-813","source":"Crossref","is-referenced-by-count":26,"title":["Risk prediction of COVID-19 incidence and mortality in a large multi-national hemodialysis cohort: implications for management of the pandemic in outpatient hemodialysis settings"],"prefix":"10.1093","volume":"14","author":[{"given":"Mathias","family":"Haarhaus","sequence":"first","affiliation":[{"name":"Diaverum AB, Malm\u00f6, Sweden"},{"name":"Department of Clinical Sciences, Intervention and Technology, Division of Renal Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden"}]},{"given":"Carla","family":"Santos","sequence":"additional","affiliation":[{"name":"Diaverum AB, Malm\u00f6, Sweden"},{"name":"Faculty of Medicine, Cardiovascular Research and Development Unit, Porto, Portugal"}]},{"given":"Michael","family":"Haase","sequence":"additional","affiliation":[{"name":"Diaverum AB, Malm\u00f6, Sweden"},{"name":"Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany"}]},{"given":"Pedro","family":"Mota Veiga","sequence":"additional","affiliation":[{"name":"Polytechnic Institute of Viseu, School of Education, Viseu, Portugal"},{"name":"NECE Research Unit in Business Sciences, University of Beira Interior, Covilh\u00e3, Portugal"}]},{"given":"Carlos","family":"Lucas","sequence":"additional","affiliation":[{"name":"Diaverum AB, Malm\u00f6, Sweden"}]},{"given":"Fernando","family":"Macario","sequence":"additional","affiliation":[{"name":"Diaverum AB, Malm\u00f6, Sweden"}]}],"member":"286","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"2021032313074800300_sfab037-B1","doi-asserted-by":"crossref","DOI":"10.1177\/1178633720952076","article-title":"Clinical presentation of patients infected with coronavirus disease 19: asystematic review","volume":"13","author":"Sheleme","year":"2020","journal-title":"Infect Dis (Auckl)"},{"key":"2021032313074800300_sfab037-B2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.kint.2020.04.030","article-title":"A report from the Brescia renal COVID task force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection","volume":"98","author":"Alberici","year":"2020","journal-title":"Kidney Int"},{"key":"2021032313074800300_sfab037-B3","first-page":"1519\u20131529","article-title":"Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients","volume":"98","author":"C\u00e9cile","year":"2020","journal-title":"Kidney Int"},{"key":"2021032313074800300_sfab037-B4","first-page":"1815\u20131823","article-title":"Epidemiology of COVID-19 in an urban dialysis center","volume":"31","author":"Corbett","year":"2020","journal-title":"J Am SocNephrol"},{"key":"2021032313074800300_sfab037-B5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40620-020-00794-1","article-title":"Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: survey of the Italian Society of Nephrology","volume":"33","author":"Quintaliani","year":"2020","journal-title":"J Nephrol"},{"key":"2021032313074800300_sfab037-B6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/s41591-020-0949-6","article-title":"Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China","volume":"26","author":"Xu","year":"2020","journal-title":"Nat Med"},{"key":"2021032313074800300_sfab037-B7","doi-asserted-by":"crossref","first-page":"1335\u20131344","DOI":"10.1016\/S0140-6736(20)32009-2","article-title":"Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study","volume":"396","author":"Anand","year":"2020","journal-title":"Lancet"},{"key":"2021032313074800300_sfab037-B8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","article-title":"Robust T cell immunity in convalescent Individuals with asymptomatic or mild COVID-19","volume":"183","author":"Sekine","year":"2020","journal-title":"Cell"},{"key":"2021032313074800300_sfab037-B9","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1093\/ndt\/gfaa261","article-title":"COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration","volume":"35","author":"Hilbrands","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2021032313074800300_sfab037-B10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"2021032313074800300_sfab037-B11","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jclinepi.2007.03.003","article-title":"Imputation is beneficial for handling missing data in predictive models","volume":"60","author":"Steyerberg","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"2021032313074800300_sfab037-B12","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"key":"2021032313074800300_sfab037-B13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/heartjnl-2011-301246","article-title":"Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio)marker","volume":"98","author":"Moons","year":"2012","journal-title":"Heart"},{"key":"2021032313074800300_sfab037-B14","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models: efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"2021032313074800300_sfab037-B15","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"key":"2021032313074800300_sfab037-B16","first-page":"334","article-title":"SARS-CoV-2 infection in dialysis patients in northern Italy: a single-centre experience","volume":"13","author":"Fontana","year":"2020","journal-title":"Clin Kidney J"},{"key":"2021032313074800300_sfab037-B17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/ckj\/sfaa119","article-title":"The keys to control a COVID-19 outbreak in a haemodialysis unit","volume":"13","author":"Rinc\u00f3n","year":"2020","journal-title":"Clin Kidney J"},{"key":"2021032313074800300_sfab037-B18","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/ndt\/gfaa170","article-title":"Impact of first-wave COronaVIrus disease 2019 infection in patients on haemoDIALysis in Alsace: the observational COVIDIAL study","volume":"35","author":"Keller","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"2021032313074800300_sfab037-B19","first-page":"1387","article-title":"Clinical characteristics of and medical interventions for COVID-19 in hemodialysispatients in Wuhan","volume":"31","author":"Xiong","year":"2020","journal-title":"J Am SocNephrol"},{"key":"2021032313074800300_sfab037-B20","doi-asserted-by":"crossref","first-page":"690\u2013695.e1","DOI":"10.1053\/j.ajkd.2020.07.001","article-title":"COVID-19 outbreak in an urban hemodialysisunit","volume":"76","author":"Yau","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"2021032313074800300_sfab037-B21","doi-asserted-by":"crossref","first-page":"ciaa1270","DOI":"10.1093\/cid\/ciaa1270","article-title":"Outbreak of COVID-19 in a nursing home associated with aerosol transmission as a result of inadequate ventilation","author":"de Man","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021032313074800300_sfab037-B22","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.15585\/mmwr.mm6934a4","article-title":"Notes from the field: universal statewidelaboratory testing for SARS-CoV-2 in nursing homes - West Virginia, April 21-May 8, 2020","volume":"69","author":"McBee","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021032313074800300_sfab037-B23","article-title":"Outbreak of COVID-19 at three nursing homes in Bergen","volume":"140","author":"Kittang","year":"2020","journal-title":"Tidsskr nor Laegeforen"},{"key":"2021032313074800300_sfab037-B24","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.ekir.2020.07.010","article-title":"The cumulative rate of SARS-CoV-2 infection in Chinese hemodialysispatients","volume":"5","author":"Xu","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2021032313074800300_sfab037-B25","first-page":":919\u2013930","article-title":"Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with COVID-19: asystematic review and meta-analysis","volume":"18","author":"Lo","year":"2020","journal-title":"Expert Rev CardiovascTher"},{"key":"2021032313074800300_sfab037-B26","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","article-title":"Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people","volume":"106","author":"Hippisley-Cox","year":"2020","journal-title":"Heart"},{"key":"2021032313074800300_sfab037-B27","doi-asserted-by":"crossref","first-page":"H2373","DOI":"10.1152\/ajpheart.00426.2008","article-title":"Regulation of ACE2 in cardiac myocytes and fibroblasts","volume":"295","author":"Gallagher","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2021032313074800300_sfab037-B28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000507305","article-title":"Should COVID-19 concern nephrologists? Why and to Whatextent? The emerging impasse of angiotensin blockade","volume":"144","author":"Perico","year":"2020","journal-title":"Nephron"},{"key":"2021032313074800300_sfab037-B29","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2021032313074800300_sfab037-B30","doi-asserted-by":"crossref","first-page":"173545","DOI":"10.1016\/j.ejphar.2020.173545","article-title":"Should ACE2 be given a chance in COVID-19 therapeutics: A semi-systematic review of strategies enhancing ACE2","volume":"887","author":"Kaur","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"2021032313074800300_sfab037-B31","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"2021032313074800300_sfab037-B32","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/HJH.0000000000002495","article-title":"Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman\u2019s syndromes patients","volume":"38","author":"Cal\u00f2","year":"2020","journal-title":"J Hypertens"},{"key":"2021032313074800300_sfab037-B33","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"2021032313074800300_sfab037-B34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2215\/CJN.03880411","article-title":"Seasonal variations in mortality, clinical, and laboratory parameters in hemodialysis patients: a 5-year cohort study","volume":"7","author":"Usvyat","year":"2012","journal-title":"Clin J Am SocNephrol"},{"key":"2021032313074800300_sfab037-B35","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/s41598-020-59153-6","article-title":"Seasonal variations in cause-specific mortality and transition to renal replacement therapy among patients with end-stage renal disease","volume":"10","author":"Goto","year":"2020","journal-title":"Sci Rep"},{"key":"2021032313074800300_sfab037-B36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0141076820956802","article-title":"Excess mortality: the gold standard in measuring the impact of COVID-19 worldwide?","volume":"113","author":"Beaney","year":"2020","journal-title":"J R Soc Med"},{"key":"2021032313074800300_sfab037-B37","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/STROKEAHA.120.030365","article-title":"Clinical characteristics and outcomes of COVID-19 patients with a history of stroke in Wuhan, China","volume":"51","author":"Qin","year":"2020","journal-title":"Stroke"},{"key":"2021032313074800300_sfab037-B38","first-page":"985\u2013993","article-title":"Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak","volume":"; 73","author":"Solano-L\u00f3pez","year":"2020","journal-title":"Rev EspCardiol (Engl Ed)"},{"key":"2021032313074800300_sfab037-B39","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(20)30854-0","article-title":"Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study","volume":"395","author":"Banerjee","year":"2020","journal-title":"Lancet"},{"key":"2021032313074800300_sfab037-B40","doi-asserted-by":"crossref","first-page":"e0216415","DOI":"10.1371\/journal.pone.0216415","article-title":"Malnutrition, inflammation, progression of vascular calcification and survival: Inter-relationships in hemodialysis patients","volume":"14","author":"Choi","year":"2019","journal-title":"PLoS One"},{"key":"2021032313074800300_sfab037-B41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneph.2013.44","article-title":"Immune cell dysfunction and inflammation in end-stage renal disease","volume":"9","author":"Betjes","year":"2013","journal-title":"Nat Rev Nephrol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfab037\/36200511\/sfab037.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/14\/3\/805\/36670497\/sfab037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/14\/3\/805\/36670497\/sfab037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T13:13:11Z","timestamp":1616505191000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/14\/3\/805\/6129258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,5]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,2,5]]},"published-print":{"date-parts":[[2021,3,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfab037","relation":{},"ISSN":["2048-8513"],"issn-type":[{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2021,2,5]]}}}